Palo Alto Investors LP Long-Term Concentrated

Location: Palo Alto, CA

CIK: 0001306923 · Show all filings

Period: Q1 2017 (← Previous) (Next →)

Filing Date: May 15, 2017

Total Value: $2.116B (100.0% shares, 0.0% debt)

Holdings (39)

UTHR UNITED THERAPEUTICS CORP DEL 12.1%
Value $255M Shares 1,883,315 Share Price $135.38 * Est. Cost/Share $88.34 Unrealized @ Report Date +71.5%
— CLOVIS ONCOLOGY INC 11.7%
Value $248M Shares 3,894,963 Share Price $63.67 Est. Cost/Share $54.10 Unrealized @ Report Date —
— ABIOMED INC 11.4%
Value $241M Shares 1,921,484 Share Price $125.20 Est. Cost/Share $30.32 Unrealized @ Report Date —
BMRN BIOMARIN PHARMACEUTICAL INC 9.9%
Value $209M Shares 2,382,619 Share Price $87.78 Est. Cost/Share $79.29 Unrealized @ Report Date +12.2%
— ALEXION PHARMACEUTICALS INC 5.9%
Value $125M Shares 1,027,060 Share Price $121.24 Est. Cost/Share $120.21 Unrealized @ Report Date —
— ZELTIQ AESTHETICS INC 5.3%
Value $113M Shares 2,032,692 Share Price $55.61 Est. Cost/Share $33.92 Unrealized @ Report Date —
INSM INSMED INC 4.6%
Value $96.9M Shares 5,534,150 Share Price $17.51 * Est. Cost/Share $14.57 Unrealized @ Report Date +5.8%
— EPIZYME INC 3.9%
Value $82.17M Shares 4,791,051 Share Price $17.15 Est. Cost/Share $14.80 Unrealized @ Report Date —
— WRIGHT MED GROUP N V 3.9%
Value $81.79M Shares 2,628,193 Share Price $31.12 Est. Cost/Share $23.37 Unrealized @ Report Date —
— SAGE THERAPEUTICS INC 3.7%
Value $78.32M Shares 1,101,951 Share Price $71.07 Est. Cost/Share $42.59 Unrealized @ Report Date —
— AMAG PHARMACEUTICALS INC 3.6%
Value $75.42M Shares 3,344,620 Share Price $22.55 Est. Cost/Share $29.94 Unrealized @ Report Date —
PRTA PROTHENA CORP PLC 2.8%
Value $58.91M Shares 1,055,855 Share Price $55.79 * Est. Cost/Share $32.05 Unrealized @ Report Date +63.9%
VNDA VANDA PHARMACEUTICALS INC 2.8%
Value $58.85M Shares 4,203,270 Share Price $14.00 Est. Cost/Share $8.70 Unrealized @ Report Date +63.7%
FOLD AMICUS THERAPEUTICS INC 2.7%
Value $56.21M Shares 7,882,988 Share Price $7.13 * Est. Cost/Share $6.23 Unrealized @ Report Date +1.4%
ACAD ACADIA PHARMACEUTICALS INC 2.6%
Value $54.68M Shares 1,590,430 Share Price $34.38 * Est. Cost/Share $29.78 Unrealized @ Report Date +18.5%
— KARYOPHARM THERAPEUTICS INC 2.1%
Value $43.74M Shares 3,406,475 Share Price $12.84 Est. Cost/Share $19.89 Unrealized @ Report Date —
— CELGENE CORP 1.7%
Value $36.74M Shares 295,240 Share Price $124.43 Est. Cost/Share $97.51 Unrealized @ Report Date —
STAA STAAR SURGICAL CO 1.6%
Value $34.04M Shares 3,473,170 Share Price $9.80 Est. Cost/Share $7.97 Unrealized @ Report Date +25.1%
ALGN ALIGN TECHNOLOGY INC 1.2%
Value $25.59M Shares 223,107 Share Price $114.71 * Est. Cost/Share $94.04 Unrealized @ Report Date +7.4%
— AIMMUNE THERAPEUTICS INC 1.2%
Value $25.5M Shares 1,173,498 Share Price $21.73 Est. Cost/Share $22.42 Unrealized @ Report Date —
GILD GILEAD SCIENCES INC 1.1%
Value $23.88M Shares 351,600 Share Price $67.92 * Est. Cost/Share $62.02 Unrealized @ Report Date -18.3%
— MOMENTA PHARMACEUTICALS INC 1.1%
Value $23.49M Shares 1,759,376 Share Price $13.35 Est. Cost/Share $14.08 Unrealized @ Report Date —
— SHIRE PLC 1.1%
Value $22.68M Shares 130,200 Share Price $174.23 Est. Cost/Share $219.26 Unrealized @ Report Date —
— RIGEL PHARMACEUTICALS INC 0.7%
Value $14.08M Shares 4,254,623 Share Price $3.31 Est. Cost/Share $3.39 Unrealized @ Report Date —
EXAS EXACT SCIENCES CORP 0.5%
Value $10.04M Shares 425,276 Share Price $23.62 * Est. Cost/Share $13.30 Unrealized @ Report Date +49.0%
— SUNESIS PHARMACEUTICALS INC 0.2%
Value $4.766M Shares 1,162,473 Share Price $4.10 Est. Cost/Share $4.37 Unrealized @ Report Date —
— ALIMERA SCIENCES INC 0.2%
Value $4.219M Shares 3,013,793 Share Price $1.40 Est. Cost/Share $4.88 Unrealized @ Report Date —
— ACELRX PHARMACEUTICALS INC 0.2%
Value $3.253M Shares 1,032,715 Share Price $3.15 Est. Cost/Share $5.54 Unrealized @ Report Date —
— DICERNA PHARMACEUTICALS INC 0.1%
Value $1.637M Shares 481,519 Share Price $3.40 Est. Cost/Share $5.48 Unrealized @ Report Date —
CYTK CYTOKINETICS INC 0.1%
Value $1.589M Shares 123,686 Share Price $12.85 * Est. Cost/Share $6.71 Unrealized @ Report Date +74.1%
— IDERA PHARMACEUTICALS INC 0.1%
Value $1.522M Shares 616,355 Share Price $2.47 Est. Cost/Share $3.70 Unrealized @ Report Date —
— CEMPRA INC 0.1%
Value $1.276M Shares 340,320 Share Price $3.75 Est. Cost/Share $22.71 Unrealized @ Report Date —
— Trevena Inc 0.1%
Value $1.253M Shares 341,300 Share Price $3.67 Est. Cost/Share $3.67 Unrealized @ Report Date —
— INTREXON CORP 0.0%
Value $830K Shares 41,900 Share Price $19.81 Est. Cost/Share $28.82 Unrealized @ Report Date —
— SOPHIRIS BIO INC 0.0%
Value $699K Shares 247,000 Share Price $2.83 Est. Cost/Share $2.60 Unrealized @ Report Date —
— HISTOGENICS CORP 0.0%
Value $524K Shares 302,922 Share Price $1.73 Est. Cost/Share $11.00 Unrealized @ Report Date —
— ZOGENIX INC 0.0%
Value $320K Shares 29,500 Share Price $10.85 Est. Cost/Share $13.36 Unrealized @ Report Date —
— ALCOBRA LTD 0.0%
Value $311K Shares 272,788 Share Price $1.14 Est. Cost/Share $5.98 Unrealized @ Report Date —
— CAPNIA INC 0.0%
Value $301K Shares 423,738 Share Price $0.71 Est. Cost/Share $0.71 Unrealized @ Report Date —